BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11916790)

  • 21. Effects of vecuronium and rocuronium in antagonistic laryngeal muscles and the anterior tibial muscle in the cat.
    Michalek-Sauberer A; Gilly H; Steinbereithner K; Vizi ES
    Acta Anaesthesiol Scand; 2000 May; 44(5):503-10. PubMed ID: 10786732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between rosuvastatin and rocuronium in rat sciatic-gastrocnemius nerve-muscle preparation.
    Panchasara AK; Patel JC; Vadgama VK; Barvaliya MJ; Tripathi CB
    J Anesth; 2014 Oct; 28(5):727-32. PubMed ID: 24557086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacology of a new short-acting, non-depolarising muscle relaxant steroid (RGH-4201).
    Biró K; Kárpáti E
    Arzneimittelforschung; 1981; 31(11):1918-24. PubMed ID: 6172135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
    de Boer HD; van Egmond J; van de Pol F; Bom A; Driessen JJ; Booij LH
    Br J Anaesth; 2006 Nov; 97(5):681-6. PubMed ID: 17018564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
    Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
    Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuromuscular effects of rocuronium during sevoflurane, isoflurane, and intravenous anesthesia.
    Lowry DW; Mirakhur RK; McCarthy GJ; Carroll MT; McCourt KC
    Anesth Analg; 1998 Oct; 87(4):936-40. PubMed ID: 9768798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response relationship of rocuronium bromide during intravenous anaesthesia.
    Mellinghoff H; Diefenbach C; Bischoff A; Grond S; Buzello W
    Eur J Anaesthesiol Suppl; 1994; 9():20-4. PubMed ID: 7925204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuromuscular recovery following rocuronium bromide single dose in infants.
    Rapp HJ; Altenmueller CA; Waschke C
    Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An overview of the pharmacokinetics and pharmacodynamics of rocuronium bromide].
    Iwasaki H
    Masui; 2006 Jul; 55(7):826-33. PubMed ID: 16856542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block.
    Shields M; Giovannelli M; Mirakhur RK; Moppett I; Adams J; Hermens Y
    Br J Anaesth; 2006 Jan; 96(1):36-43. PubMed ID: 16357116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different priming techniques, including mivacurium, accelerate the onset of rocuronium.
    Naguib M
    Can J Anaesth; 1994 Oct; 41(10):902-7. PubMed ID: 8001208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenobarbital influence on neuromuscular block produced by rocuronium in rats.
    Braga Ade F; Barcelos CC; Braga FS; Fernandes SC; Franco YO; Mantovani M; Simioni LR
    Acta Cir Bras; 2008; 23(4):343-7. PubMed ID: 18641804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy.
    Wick S; Muenster T; Schmidt J; Forst J; Schmitt HJ
    Anesthesiology; 2005 May; 102(5):915-9. PubMed ID: 15851877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of neuromuscular block is more variable and recovery time is shorter with rocuronium than cisatracurium in anesthetized dogs.
    Martin-Flores M; Hackman MC; Araos JD; Campoy L; Gleed RD
    Vet Ophthalmol; 2023 Sep; 26(5):407-413. PubMed ID: 36799561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of time of day on the duration of neuromuscular blockade elicited by rocuronium.
    Cheeseman JF; Merry AF; Pawley MD; de Souza RL; Warman GR
    Anaesthesia; 2007 Nov; 62(11):1114-20. PubMed ID: 17924891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recovery from prolonged deep rocuronium-induced neuromuscular blockade: A randomized comparison of sugammadex reversal with spontaneous recovery.
    Rahe-Meyer N; Berger C; Wittmann M; Solomon C; Abels EA; Rietbergen H; Reuter DA
    Anaesthesist; 2015 Jul; 64(7):506-12. PubMed ID: 26126940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Review on Rocuronium Continuous Infusion for Deep Neuromuscular Blockade.
    Couto M; Couto JG; Nunes CS; Vide S; Amorim P; Mendes J
    Curr Rev Clin Exp Pharmacol; 2021; 16(1):64-72. PubMed ID: 31750807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.